SAN ANTONIO, Dec. ... VeriSIM Life provides insights to pharma, biotech, academia, and research institutions and conducts risk-sharing ...
News
- VeriSIM Life Earns Frost & Sullivan Competitive Strategy Leadership Award for Best ...
- Texas Biomed sees potential research funding rise alongside its national readiness profile
Credit: Nick Wagner / San Antonio Report ... The Texas Biomedical Research Institute announced Tuesday it has been elevated by the Biomedical ...
- Lantern Pharma Announces Development of Drug Candidate LP-184 for Triple Negative ...
New positive preclinical data on the anti-tumor potency of LP-184 for TNBCs was recently presented at the San Antonio Breast Cancer Symposium (SABCS) ...
- vTv Therapeutics (VTVT) Appoints Biotech Industry Veteran Steven Tuch as Chief Financial Officer
... Lantern Pharma (LTRN) Announces Development of Drug Candidate LP-184 for Triple Negative Breast Cancer (TNBC) at the San Antonio Breast Cancer ...
- Blue Water Vaccines Announces Institutional Research Coverage by Two Notable ... - BioSpace
... Cincinnati Children's Hospital Medical Center, St. Jude Children's Hospital, and The University of Texas Health San Antonio.